Quick Answer
INTUITIVE SURGICAL INC reported Research And Development Expense of $1.31 billion for the year ending 2025.
- INTUITIVE SURGICAL INC showed an increase of +14.5% in Research And Development Expense from 2024 to 2025.
- This data is from INTUITIVE SURGICAL INC's annual report (Form 10-K), filed with the SEC on February 3, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2010: $28.00 million | Q2 2010: $28.50 million | Q3 2010: $26.90 million | Q1 2011: $31.40 million | Q2 2011: $32.00 million | Q3 2011: $35.40 million | Q1 2012: $38.40 million | Q2 2012: $40.20 million | Q3 2012: $49.70 million | Q1 2013: $41.60 million | Q2 2013: $41.20 million | Q3 2013: $43.20 million | Q1 2014: $43.00 million | Q2 2014: $40.20 million | Q3 2014: $47.50 million | Q1 2015: $44.40 million | Q2 2015: $49.40 million | Q3 2015: $51.00 million | Q1 2016: $53.20 million | Q2 2016: $54.70 million | Q3 2016: $62.60 million | Q1 2017: $73.50 million | Q2 2017: $84.60 million | Q3 2017: $83.40 million | Q1 2018: $95.50 million | Q2 2018: $95.10 million | Q3 2018: $107.60 million | Q1 2019: $144.00 million | Q2 2019: $120.80 million | Q3 2019: $135.90 million | Q1 2020: $147.10 million | Q2 2020: $143.20 million | Q3 2020: $155.00 million | Q1 2021: $159.80 million | Q2 2021: $162.30 million | Q3 2021: $165.50 million | Q1 2022: $210.50 million | Q2 2022: $207.30 million | Q3 2022: $217.10 million | Q1 2023: $244.90 million | Q2 2023: $244.40 million | Q3 2023: $249.40 million | Q1 2024: $284.50 million | Q2 2024: $280.10 million | Q3 2024: $286.00 million | Q1 2025: $316.20 million | Q2 2025: $313.30 million | Q3 2025: $329.40 million.
- Over the full 18 years of available data (2008 to 2025), INTUITIVE SURGICAL INC's Research And Development Expense has grown by 1,552.1%.
- Historical annual values: Fiscal year 2025: $1.31 billion | Fiscal year 2024: $1.15 billion | Fiscal year 2023: $998.80 million | Fiscal year 2022: $879.00 million | Fiscal year 2021: $671.00 million | Fiscal year 2020: $595.10 million | Fiscal year 2019: $557.30 million | Fiscal year 2018: $418.10 million | Fiscal year 2017: $328.60 million | Fiscal year 2016: $239.60 million | Fiscal year 2015: $197.40 million | Fiscal year 2014: $178.00 million | Fiscal year 2013: $167.70 million | Fiscal year 2012: $170.00 million | Fiscal year 2011: $140.20 million | Fiscal year 2010: $116.00 million | Fiscal year 2009: $95.10 million | Fiscal year 2008: $79.40 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: